![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | C07D 207/48 | |
C07C 55/10 | |||
C07C 57/15 | |||
A61K 31/40 | |||
A61P 1/04 |
(11) | Number of the document | 3433232 |
(13) | Kind of document | T |
(96) | European patent application number | 17770545.6 |
Date of filing the European patent application | 2017-03-17 | |
(97) | Date of publication of the European application | 2019-01-30 |
(45) | Date of publication and mention of the grant of the patent | 2020-07-15 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/KR2017/002913 |
Date | 2017-03-17 |
(87) | Number | WO 2017/164575 |
Date | 2017-09-28 |
(30) | Number | Date | Country code |
20160036081 | 2016-03-25 | KR | |
20170018336 | 2017-02-09 | KR |
(72) |
KIM, Aeri, KR
CHO, Kwan Hyung, KR
|
(73) |
Daewoong Pharmaceutical Co., Ltd.,
35-14, Jeyakgongdan 4-gil, Hyangnam-eup, Hwaseong-si Gyenoggi-do 18623,
KR
|
(54) | NOVEL ACID ADDITION SALT OF 1-(5-(2,4-DIFLUOROPHENYL)-1-((3- FLUOROPHENYL)SULFONYL)-4-METHOXY-1H-PYRROL-3-YL)-N- METHYLMETHANAMINE |
NOVEL ACID ADDITION SALT OF 1-(5-(2,4-DIFLUOROPHENYL)-1-((3- FLUOROPHENYL)SULFONYL)-4-METHOXY-1H-PYRROL-3-YL)-N- METHYLMETHANAMINE |